Loading company financials…
NYSE · Electromedical & Electrotherapeutic Apparatus · CIK 0001613103
$94.17
+3.22% · delayed 15 min
$120.55B market value
What this company does
Medtronic makes medical devices and equipment. It took in $36.36B last year, which makes it a large company. Of every dollar it sells, about 13 cents is left as profit.
Financial health
Strong finances across the board.
From Medtronic plc's FY2026 annual filing · share price scored separately
Every check behind the three models, and what each one tests
Measured against FY2025, from the 10-K
Improved: +8.4%
$33.54B to $36.36B
Deteriorated: -12.1%
$2.22B to $1.95B
6 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Nothing here reads the management commentary, which is where a company explains its own numbers.
It makes a profit rather than burning through money.
$4.80B earned last year
Day-to-day operations generate real cash, not just accounting profit.
$7.33B cash from operations
It holds more cash than debt, so borrowings are not a pressure.
$161.0M more cash than debt
It passes almost every standard check of financial strength.
Piotroski 7/8
Nothing in the filings stands out as a concern.
Filter by minute, hour, day or week
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 7% a year for the next 10 years. Over the last 10 years it grew by about 3% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 13 cents of every dollar of sales as profit, earning $4.80B last year.
What it earns, what it keeps, and what it costs to run — all from the same filing
Whether the dividend is covered by what the business actually earns
It pays out 76 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 50% of the cash its operations generated. It has paid in each of the last 12 years.
GoodNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2026 annual filing
Last year it earned $4.80B and generated $7.33B of cash from operations.
Reported annual figures
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Go deeper
Every figure above traces back to one of these filings.
Straight from SEC EDGAR — the original source for every figure above
| Filing | Filed | Covers to |
|---|---|---|
| Quarterly report(10-Q) | 2026-09-03 | 2026-07-31 |
| Major event announcement(8-K) | 2026-09-01 | 2026-09-01 |
Financial figures are from MDT's 10-K for fiscal year 2026 (period ending 2026-04-24), reported under the US GAAP taxonomy. View the source filing.
7 of 8 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. One could not be evaluated and is excluded from the total rather than counted as a failure.
2.96
In the grey zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2026 filing as filed with the SEC.
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 5% and 9%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 1.1% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
Slowly. Sales grew 8.4% last year.
No — it holds more cash than debt, with $161.0M left over after paying off every borrowing. For every $1 it owes, it owns $2.17 in assets.
Around average. Investors pay $25.1 for every $1 of yearly profit.
This company has not reported enough of the required figures to calculate this score.
At a glance
| Shareholder voting information(DEF 14A) | 2026-08-17 | 2026-10-15 |
| Annual report(10-K) | 2026-06-18 | 2026-04-24 |
| Major event announcement(8-K) | 2026-06-03 | 2026-06-03 |
| Major event announcement(8-K) | 2026-05-18 | 2026-05-18 |
| Major event announcement(8-K) | 2026-04-27 | 2026-04-24 |
| Major event announcement(8-K) | 2026-03-24 | 2026-03-24 |
| Quarterly report(10-Q) | 2026-02-24 | 2026-01-23 |
| Major event announcement(8-K) | 2026-02-17 | 2026-02-17 |
| Quarterly report(10-Q) | 2025-11-25 | 2025-10-24 |
| Major event announcement(8-K) | 2025-11-18 | 2025-11-18 |
| Major event announcement(8-K) | 2025-11-03 | 2025-11-01 |
| Major event announcement(8-K) | 2025-10-21 | 2025-10-16 |
| Major event announcement(8-K) | 2025-09-29 | 2025-09-29 |
| Major event announcement(8-K) | 2025-09-16 | 2025-09-15 |
| Quarterly report(10-Q) | 2025-08-26 | 2025-07-25 |
| Shareholder voting information(DEF 14A) | 2025-08-25 | 2025-10-16 |
| Major event announcement(8-K) | 2025-08-19 | 2025-08-18 |
| Major event announcement(8-K) | 2025-06-23 | 2025-06-18 |
Coverage from the last 30 days
Medtronic executives to speak at upcoming investor conferences
Yahoo Finance ·
4 Reasons to Buy Medtronic Stock Like There's No Tomorrow
Yahoo Finance ·
Is Medtronic Stock Underperforming the Dow?
Yahoo Finance ·
Medtronic Begins Fiscal 2027 With a Beat-and-Raise, Validating Growth Acceleration, RBC Says
Yahoo Finance ·
MDT Q1 Earnings Call Focuses on Broad Growth, Raised Guidance
Yahoo Finance ·
Medtronic raises FY27 outlook after reporting strong Q1 growth
Yahoo Finance ·
Global Surgical Robots Market to Reach $10.6 Billion in 2026, Driven by AI Integration and Minimally Invasive Surgery
Yahoo Finance ·
Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?
Yahoo Finance ·
ISRG's Ion Platform Is Quietly Becoming a Second Growth Engine
Yahoo Finance ·
How Much Upside Can BSX Stock's Growth Deliver?
Yahoo Finance ·
Was JNJ Stock Rally Actually Its Own?
Yahoo Finance ·
Is Johnson & Johnson Stock Priced For More Growth Than It Has Guided?
Yahoo Finance ·
Primary sources and further research